Work

Cerebrospinal fluid abnormalities in a phase III trial of Avonex® (IFNβ-1a) for relapsing multiple sclerosis1Studies supported by the National Multiple Sclerosis Society (grants RG2019, RG2827); the NINDS (NS26321); and Biogen Inc.1

Year: 1999
Type: article
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W1244620587
FWCI: 5.719
Cites: 26
Cited by: 104
Related to: 10